Micron Biomedical Announces The Lancet Publication of Positive Phase 1/2 Data From First Clinical Trial of Needle-Free Vaccines in Children ...Middle East

PR Newswire - News
Micron's technology class, prioritized by the World Health Organization and others for eradicating disease, demonstrates tolerability, safety and immunogenicity of a measles and rubella vaccine Micron's technology will be evaluated in additional clinical trials within the next 12 months...

Read More Details
Finally We wish PressBee provided you with enough information of ( Micron Biomedical Announces The Lancet Publication of Positive Phase 1/2 Data From First Clinical Trial of Needle-Free Vaccines in Children )

Apple Storegoogle play

Also on site :